Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2008
12/10/2008CN101317570A Agricultural bactericide, preparation and application thereof
12/10/2008CN100441556C Triphenylalkene derivatives and their use as selective estrogen receptor modulators
12/09/2008US7462723 e.g. N1-[(E)-1-(4-fluorophenyl)methylidene]-4-(1,3-thiazol-2-yl)-1H-1,2-imidazolediamine; anticarcinogenic agent; sid effect reduction
12/09/2008US7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds
12/09/2008US7462617 Substituted acylpiperazine derivatives
12/09/2008US7462608 Non nucleoside reverse transcriptase inhibitors
12/04/2008WO2008145616A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
12/04/2008WO2008145562A1 Non-nucleoside reverse transcriptase inhibitors
12/04/2008WO2008110007A8 Imidazolium-type ionic oligomers
12/04/2008WO2008002849A3 Aryl sulfones
12/04/2008US20080300348 Polymer
12/04/2008US20080300290 Novel Beta-Agonists, Process for Their Preparation and Their Use as Medicaments
12/04/2008US20080296305 Fluid Storage and Purification Method and System
12/04/2008CA2687747A1 Non-nucleoside reverse transcriptase inhibitors
12/04/2008CA2686651A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
12/03/2008EP1786776B1 Method for producing high-purity quaternary ammonium compounds
12/03/2008EP1373218B9 Imidazolyl derivatives useful as histamine h3 receptor ligands
12/03/2008EP1353638A4 Novel couplers for use in oxidative hair dyeing
12/03/2008EP1353637A4 Novel couplers for use in oxidative hair dyeing
12/03/2008CN101316824A Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests
12/03/2008CN101316823A 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and MDM2 proteins for use as anticancer agents
12/03/2008CN101315378A Method and special ELISA reagent kit for detecting nitryl imidazole medicament
12/03/2008CN101314592A Morpholine ornidazole metabolite in vivo and midbody, and preparation thereof
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/03/2008CN100439265C Method for treating condensation waste water for producing imidacloprid and resourcized recovering its imidazolidine
12/02/2008US7459580 Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives
12/02/2008US7459558 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
12/02/2008US7459479 Benzylated PDE4 inhibitors
12/02/2008CA2461622C Substituted benzimidazole compounds and their use for the treatment of cancer
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2008142591A2 3- to 7-membered 1,3-diaza-4-oxo-heterocyclic derivatives capable of releasing active aldehydes or ketones
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080293951 Amin Derivative, and Production Method and Use Thereof
11/27/2008US20080293792 (R)-2-(9-(1H-imidazol-1-yl)nonyl)-2,5,7,8-tetramethylchroman-6-ol, capable of inhibiting tocopherol-omega-hydroxylase, responsible for the metabolism of tocopherol and tocotrienol compounds of vitamin E, and thus increase the amount and prolong the bioavailability of these compounds in plasma and tissue
11/27/2008US20080293751 Tetralin and indane derivatives and uses thereof
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293722 Ion Channel Modulators
11/27/2008US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
11/27/2008US20080293569 Indanyl- and Tetrahydronaphthyl-Amino-Azoline Compounds for Combating Animal Pests
11/27/2008US20080292582 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
11/27/2008CA2687975A1 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
11/26/2008EP1994009A1 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones
11/26/2008EP1506162B1 Synthesis of benzonitriles and benzimidates
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008CN101311169A Method for preparing 4-(1-hydroxyl-1-methyl ethyl)-2-propyl glyoxaline-5-carboxyl acetate
11/26/2008CN101311168A Method for preparing 4-(1-hydroxyl-1-methyl ethyl)-2-propyl glyoxaline-5-carboxylic ether
11/26/2008CN101311167A 1-phenyl glyoxaline alkane -2,4-dione derivates and uses thereof
11/26/2008CN100436450C Novel triarylimidazoles
11/26/2008CN100436425C Fused imidazolium derivatives
11/26/2008CN100436424C Ion liquid of containing anisomerous dicentric positive ion, and preparation method
11/25/2008US7456294 Hairpin polyamide
11/25/2008US7456208 CCK-1 receptor modulators
11/20/2008WO2008140338A1 New ionic pairs with (4-chloro-2-methylphenoxy)acetate and their syntheses
11/20/2008US20080287686 Process for Preparing Onium Salts
11/20/2008US20080287685 Detomidine Hydrochloride Crystallization Method
11/20/2008US20080287684 Method for Producing Ionic Liquids
11/20/2008US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
11/20/2008US20080287506 Insecticidal N,N-Di(Heteroarylalkyl) Amine Derivatives
11/20/2008US20080287460 New compounds 835
11/20/2008US20080287438 Agent for preventing or treating neuropathy
11/20/2008US20080286810 Use of Inhibtors of Glutaminyl Cyclases for Treatment and Prevention of Disease
11/20/2008US20080286231 Novel inhibitors of glutaminyl cyclase
11/19/2008EP1992618A1 Polycyclic cinnamide derivative
11/19/2008EP1991528A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
11/19/2008EP1753727B1 Novel cis-imidazolines
11/19/2008EP1751131B1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
11/19/2008CN101309916A Process for production of cinnamamide derivative
11/19/2008CN101309902A Biphenyl derivatives and their use in treating hepatitis c
11/19/2008CN101309040A Thermoacoustic driving magnetohydrodynamic electricity generation system using ion liquid of room temperature
11/19/2008CN101307046A Tripeptidyl peptidase inhibitors
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN100434424C Preparation of CRGA and CRLA by ring-opening polymerization catalyst
11/18/2008US7453002 Five-membered heterocycles useful as serine protease inhibitors
11/18/2008CA2393655C Method for the preparation of enantiomerically enriched compounds
11/18/2008CA2305802C Amide derivatives or salts thereof
11/13/2008WO2008136754A1 Novel benzyl - 2 -oxo-piperazinyl/ 7-oxo/5-oxa- [1,4] diazepanyl/ 2 -oxo- tetrahydropyrimidinyl derivatives
11/13/2008WO2008136428A1 Nitrogen-containing five-membered heterocyclic compound
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008135386A1 Chiral ligands of the n-heterocyclic carbene type for asymmetrical catalysis
11/13/2008WO2008135181A2 Insecticidal substituted 2-aminoindanes
11/13/2008WO2008134840A2 Compound with anesthetics activity, methods for its production an pharmaceutical compositions comprising the same
11/13/2008WO2008065500A3 Heteroaryl amides as type i glycine transport inhibitors
11/13/2008US20080280915 {1-[6-(trifluoromethyl)pyridin-3-yl]methyl}(methyl)- lambda 4-sulfanylidenecyanamide; especially useful for the control of aphids and other sucking insects
11/13/2008US20080280869 Therapy for diseases resulting from mutation of messenger Rna; suppression prenature translation termination; autoimmune diseases; blood disorders; collagen disease; diabetes; neurodegenerative diseases; cardiovascular disorders; central nervous system disorders; antiinflammatory agents
11/13/2008US20080280769 Selective and dual-action p53/mdm2/mdm4 antagonists
11/12/2008EP1989186A1 Hydantoin based kinase inhibitors
11/12/2008EP1727808B1 Biaryl amino acids and their use in dna binding oligomers
11/12/2008EP1532117B1 Multi-substituded imidazolines and method of use thereof
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008CN101304976A Inhibitors of viral replication
11/12/2008CN101302202A Preparation of sec-butylene hydantionsec-butylene hydantion
11/12/2008CN101302201A Nitroimidazole derivate for therapy
11/12/2008CN101302171A Production process of pure amino acid chelate and use thereof
11/11/2008US7449576 potent antagonists of the CCR1 receptor; inflammation; (5-Chloro-2-piperazin-1-yl-phenyl)-phenyl-methanone
11/11/2008US7449198 Stable salts of O-acetylsalicylic acid with basic amino acids
11/06/2008WO2008133896A2 Dual-acting antihypertensive agents
11/06/2008WO2008133269A1 Ionic liquid, and polymer treatment agent comprising the ionic liquid
11/06/2008WO2008133169A1 Method for production of n-(2-amino-1,2-dicyanovinyl)imidate, method for production of n-(2-amino-1,2-dicyanovinyl)formamidine, and method for production of aminoimidazole derivative
11/06/2008WO2008132679A1 Bridged six-membered ring compounds
11/06/2008WO2008110698A3 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 345